Retirement Systems of Alabama lifted its stake in Bio-Techne Co. (NASDAQ:TECH – Free Report) by 1.0% in the fourth quarter, Holdings Channel.com reports. The firm owned 34,402 shares of the ...

The most notable increase was in Bio-Techne Corp (NASDAQ:TECH), with an additional 334,050 shares, bringing the total to 381,250 shares. This adjustment represents a significant 707.73% increase in ...

Introduction Blood cancer diagnostics refers to the process of detecting and identifying cancers that affect the blood, bone marrow, and lympha ...

The S&P 500 Index ($SPX) (SPY) today is up +0.73%, the Dow Jones Industrials Index ($DOWI) (DIA) is up +0.27%, and the Nasdaq ...

The S&P 500 Index ($SPX) (SPY) today is up +0.39%, the Dow Jones Industrials Index ($DOWI) (DIA) is up +0.25%, and the Nasdaq ...

New York, USA, Jan. 16, 2025 (GLOBE NEWSWIRE) -- Global Exosome Diagnostics Market is Projected to Boom with an Enormous CAGR of ~47% by 2032 | DelveInsight The rising incidence of cancer is ...

Bio-Techne Co. (NASDAQ:TECH – Get Free Report) gapped up prior to trading on Wednesday following a dividend announcement from the company.The stock had previously closed at $72.55, but opened at ...

Shares of Bio-Techne Corporation (NASDAQ:TECH) traded higher after the life sciences company topped analysts' expectations with its Q2 FY25 results, indicating a faster topline growth amid early ...

(RTTNews) - Bio-Techne Corp. (TECH) announced earnings for its second quarter that increased from last year and beat the Street estimates. The company's bottom line totaled $34.89 million ...

Feb 5 (Reuters) - Bio-Techne (TECH.O), opens new tab beat second-quarter profit and revenue estimates on Wednesday, helped by growth in its protein sciences unit that makes products to develop ...